PAD 134 (Hydrochlorothiazide and Moexipril Hydrochloride 12.5 mg / 15 mg)

Pill with imprint PAD 134 is White, Elliptical / Oval and has been identified as Hydrochlorothiazide and Moexipril Hydrochloride 12.5 mg / 15 mg. It is supplied by Paddock Laboratories, Inc..

Hydrochlorothiazide/moexipril is used in the treatment of high blood pressure and belongs to the drug class ACE inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/moexipril 12.5 mg / 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for PAD 134

Hydrochlorothiazide and Moexipril Hydrochloride

Imprint:

PAD 134

Strength:

12.5 mg / 15 mg

Color:

White

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

ACE inhibitors with thiazides

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Paddock Laboratories, Inc.

Inactive Ingredients:

lactose
magnesium oxide
crospovidone
magnesium stearate
povidone
silicon dioxide
hypromelloses
titanium dioxide
polyethylene glycol 400
polysorbate 80
Note: Inactive ingredients may vary.

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer